Extrapulmonary Neuroendocrine Carcinoma (EP-NEC) trials recruiting in New Jersey

Fewer than 3 recruiting trials found.

All Extrapulmonary Neuroendocrine Carcinoma (EP-NEC) trials nationally

Cities in New Jersey

Recruiting trials in New Jersey

• A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
  NCT07488923 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Hackensack
• Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
  NCT07278479 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New Jersey: Princeton